Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Dartmouth, Alcon, and More


Title: Determinants of Sensitivity to Chemotherapeutic Agents

Patent Number: 8,673,869

Filed: Dec. 14, 2005

Lead Inventor: Anna De Fazio, University of Sydney

Title: Method of Modulation of Expression of Epidermal Growth Factor Receptor Involving miRNA

Patent Number: 8,673,872

Filed: Aug. 28, 2007

Lead Inventor: Peter Leedman, University of Western Australia

Title: RNAi-mediated Inhibition of Phosphodiesterase Type 4 for Treatment of cAMP-related Ocular Conditions

Patent Number: 8,673,873

Filed: Oct. 16, 2009

Lead Inventor: John Yanni, Alcon

Title: Methods for Treating Pancreatic Cancer

Patent Number: 8,673,874

Filed: Dec. 5, 2011

Inventor: Murray Korc, Dartmouth College

Title: Method for Treating Atherosclerosis

Patent Number: 8,673,875

Filed: Dec. 11, 2012

Lead Inventor: Suh-Hang Juo, Kaohsiung Medical University